ArticleMolecular cancer therapeutics2025

A Novel B7-H4xCD3 Bispecific T-cell Engager (PF-07260437) Synergizes with Breast Cancer Standard of Care and Immune Checkpoint Therapies.

Keith Abayasiriwardana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.